Clinical Trials Logo

Schizophrenic Disorders clinical trials

View clinical trials related to Schizophrenic Disorders.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02654405 Withdrawn - Cognitive Function Clinical Trials

Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Start date: April 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this grant is to evaluate the efficacy of sodium butyrate as a novel treatment for cognitive deficits in schizophrenia (SZ). The proposal consists of a small preliminary open label study to assess tolerability and side effects of sodium butyrate in schizophrenic patients receiving antipsychotic treatment, followed by a larger double-blind study of the effects of sodium butyrate on cognitive function and symptoms in SZ patients who are not in an acute exacerbation of the primary symptoms and show continued cognitive deficits. Secondary aims will be to evaluate its effects on improving symptoms and functioning in SZ, and the relationship of the drug's clinical effects to epigenetic and inflammation related biochemical changes.

NCT ID: NCT00276263 Withdrawn - Psychotic Disorders Clinical Trials

Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia

Start date: August 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether preventative treatment with sarcosine can reduce symptoms and delay/avoid disease progression in individuals defined as being in a prodromal stage of schizophrenia.